Our Role - IPHA

Represents the interests of the international research-based pharmaceutical industry

IPHA’s main activity is to ensure that the views and interests of the international research-based pharmaceutical industry are recognised by those institutions, at home and abroad, who are involved in pharmaceutical and healthcare matters.

Builds relationships with other partners in healthcare

IPHA maintains regular contacts with all relevant institutions in and outside Ireland, e.g. Department of Health and related agencies like the Health Products Regulatory Authority (formerly the Irish Medicines Board), the Health Service Executive, the Primary Care Rimbursement Service, relevant healthcare professional organisations, the European Commission, the European Parliament, the EFPIA, the AESGP and the IFPMA.

Participates in the healthcare decision making process

IPHA is regularly consulted in draft decisions made for example by the Department of Health & Children and other Government agencies which relate to pharmaceutical and health matters.

Ensures the highest possible standards of advertising and promotion

IPHA also administers a number of Codes of Practice including the Code of Practice for the Pharmaceutical Industry and the Code of Advertising Standards for the Consumer Healthcare Industry. The objective of these Codes is to ensure the highest possible standards in the promotion and advertising of medicines.

Keeps the healthcare professions up-to-date

IPHA publishes www.medicines.ie, one of the most comprehensive sources of information on medicines. IPHA members are committed to supporting the continuing medical education of healthcare professionals and they invest heavily every year in many such programmes.

Ensures supply of the full range of innovative medicines

Pharmaceutical pricing continues to be a sensitive and difficult issue. In recognition of the funding difficulties faced by the State and in order to meet the objective of providing the full range of modern therapeutically advanced medicines to all patients regardless of income, the members of IPHA have entered into a binding Agreement with the Health Service Executive to provide the best possible value for money in relation to the purchasing of medicines for the health services in Ireland.